Integer (ITGR) Proxy filing summary

Executive summary

• KKR has announced an agreement to acquire Integer, highlighting the company's leadership in medical device contract development and manufacturing.

• KKR plans to invest in Integer's people and capabilities, aiming to deepen customer relationships and expand leadership in life-saving products.

• All associates will have the opportunity to participate in a new ownership program after the transaction closes.

• Forward-looking statements emphasize anticipated benefits, strategic rationale, and long-term growth opportunities from the transaction.

Voting matters and shareholder proposals

• Stockholders will be asked to approve the transaction and related matters at a meeting, with details to be provided in the proxy statement.

• Investors are urged to read the proxy statement and related SEC filings for important information before voting.

Board of directors and corporate governance

• Information about directors, executive officers, and their interests in the transaction will be included in the proxy statement and referenced SEC filings.

• Details on board matters and director independence are available in the annual and proxy statements.